Datametrex Passes All Proposed Resolutions During The Annual General Meeting
Datametrex AI (DTMXF) held its Annual General Meeting on November 13, 2024, with 17.15% of outstanding shares represented. Shareholders approved all proposed resolutions, including: fixing board directors at four members, re-electing directors, appointing Kingston Ross Pasnak as auditors, approving a name and symbol change, authorizing the sale of the Health Division, approving continuation from Ontario to British Columbia, approving common shares consolidation, and implementing an Omnibus Incentive Plan.
Datametrex AI (DTMXF) ha tenuto la sua Assemblea Generale Annuale il 13 novembre 2024, con il 17,15% delle azioni in circolazione rappresentate. Gli azionisti hanno approvato tutte le risoluzioni proposte, tra cui: fissare il numero dei membri del consiglio a quattro, rielezione dei direttori, nomina di Kingston Ross Pasnak come revisori, approvazione di un cambiamento di nome e simbolo, autorizzazione alla vendita della Divisione Salute, approvazione della continuazione da Ontario alla British Columbia, approvazione della consolidazione delle azioni ordinarie e implementazione di un Piano di Incentivo Omnibus.
Datametrex AI (DTMXF) celebró su Junta General Anual el 13 de noviembre de 2024, con el 17,15% de las acciones en circulación representadas. Los accionistas aprobaron todas las resoluciones propuestas, incluyendo: fijar el número de directores de la junta en cuatro miembros, la reelección de los directores, la designación de Kingston Ross Pasnak como auditores, la aprobación de un cambio de nombre y símbolo, la autorización de la venta de la División de Salud, la aprobación de la continuidad de Ontario a Columbia Británica, la aprobación de la consolidación de acciones comunes y la implementación de un Plan de Incentivos Omnibus.
Datametrex AI (DTMXF)는 2024년 11월 13일 연례 총회를 개최하였으며, 17.15%의 발행 주식이 대표되었습니다. 주주들은 모든 제안된 결의를 승인하였으며, 여기에는 이사회 이사를 네 명으로 고정하는 것, 이사 재선출, Kingston Ross Pasnak을 감사로 임명, 이름 및 기호 변경 승인, 건강 부문 판매 승인, 온타리오에서 브리티시 컬럼비아로의 계속 지원 승인, 보통주 통합 승인, 그리고 올범위 인센티브 계획 구현이 포함됩니다.
Datametrex AI (DTMXF) a tenu son Assemblée Générale Annuelle le 13 novembre 2024, avec 17,15% des actions en circulation représentées. Les actionnaires ont approuvé toutes les résolutions proposées, y compris : fixer le nombre de directeurs du conseil à quatre membres, la réélection des directeurs, la nomination de Kingston Ross Pasnak en tant qu'auditeurs, l'approbation d'un changement de nom et de symbole, l'autorisation de la vente de la Division de la Santé, l'approbation de la continuité de l'Ontario à la Colombie-Britannique, l'approbation de la consolidation des actions ordinaires et la mise en œuvre d'un Plan d'Incentives Omnibus.
Datametrex AI (DTMXF) hielt am 13. November 2024 seine Jahreshauptversammlung ab, bei der 17,15% der ausstehenden Aktien vertreten waren. Die Aktionäre genehmigten alle vorgeschlagenen Beschlüsse, darunter: die Festlegung der Anzahl der Vorstandsmitglieder auf vier, die Wiederwahl der Direktoren, die Ernennung von Kingston Ross Pasnak als Wirtschaftsprüfer, die Genehmigung einer Namens- und Symboländerung, die Genehmigung des Verkaufs der Gesundheitsabteilung, die Genehmigung der Fortführung von Ontario nach British Columbia, die Genehmigung der Konsolidierung der Stammaktien und die Umsetzung eines Omnibus-Incentive-Plans.
- Approval to sell Health Division, potentially streamlining operations
- Shareholders approved all proposed corporate restructuring initiatives
- Successfully secured approval for share consolidation, which could improve stock marketability
- Low shareholder participation rate of only 17.15% at AGM
- Pending share consolidation could lead to temporary stock price volatility
TORONTO, ON / ACCESSWIRE / November 14, 2024 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) announces the voting results from the Annual General Meeting (the "Meeting") which was held on November 13, 2024.
At the Meeting,
With the approval of the shareholders at the meeting, all the resolutions were approved, including the below:
fixing the number of directors at four (4);
re-electing directors of the Company;
appointing Kingston Ross Pasnak, LLP Chartered Professional Accountants as the auditors of the Company;
approving the name change and stock symbol;
authorizing the Corporation's sale of its Health Division;
authorizing the Continuation from the Province of Ontario to the Province of British Columbia;
approving consolidation of the Common Shares;
approving the Omnibus Incentive Plan (the "Plan")
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our YouTube channel and Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to game development and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis for the year ended December 31, 2023, available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original press release on accesswire.com
FAQ
What resolutions did Datametrex (DTMXF) pass at its November 2024 AGM?
What was the shareholder participation rate at Datametrex's (DTMXF) 2024 AGM?
Is Datametrex (DTMXF) selling its Health Division?
